Prescribing information

 

Novartis’ Severe Asthma Masterclass is a multidisciplinary educational programme that has been running since 2008 and brings together expertise from across the UK to provide high-quality educational content to help improve your clinical practice in severe asthma.

Below you can view some of the presentations from our Masterclass meeting in 2019 and our first Masterclass webinar from July 2020.

 

 

 

ALLERGIC ASTHMA – DO WE GET IT RIGHT?

Speaking at the 2019 Severe Asthma Masterclass, Dr Robin Gore discusses recent progress in severe allergic asthma, our current understanding of the disease, and the importance of having the right tools to evaluate patients.
 

 

 

 

REFLUX AND ASTHMA – WHAT IS THE RELATIONSHIP?

Speaking at the 2019 Severe Asthma Masterclass, Prof. Alyn Morice discusses the relationship between oesophageal diseases, such as cough hypersensitivity syndrome, and the treatment of asthma.
 

 

 

 

ALLERGEN AVOIDANCE – ARE WE GETTING IT RIGHT?

Speaking at the 2019 Paediatric Severe Asthma Masterclass, Dr Clare Murray discusses the role of allergen exposure in children with asthma, and whether avoidance strategies can be used to improve asthma control.
 

 

 
 
 

 

COVID-19 AND SEVERE ASTHMA

In this 2020 webinar, Prof. Andrew Menzies-Gow discusses the lessons learned from the COVID-19 pandemic and how we can use these to improve severe asthma services in the future. This is followed by an expert panel discussion chaired by Dr Rob Niven and including Prof. Andrew Menzies-Gow, Rachel Stead and Dr Helen Hope.
 

 

 
UK | December 2020 | 101356
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at http://www.report.novartis.com/
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]